SMS Pharma.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE812G01025
NSEID: SMSPHARMA
BSEID: 532815
View on NSE | View on BSE

INR

413.10

32.65 (8.58%)

BSENSE

Jun 30, 03:30 PM

BSE+NSE Vol: 80.07 lacs

{
  "main_header": {
    "sid": 517655,
    "name": "SMS Pharma.",
    "stock_name": "SMS Pharma.",
    "full_name": "SMS Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sms-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "413.10",
    "chg": 32.65,
    "chgp": "8.58%",
    "dir": 1,
    "prev_price": "380.45",
    "mcapval": "3,578.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532815,
    "symbol": "SMSPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE812G01025",
    "curr_date": "Jun 30, 03:30 PM",
    "curr_time": "17:23 PM",
    "last_traded_at": "Jun 30, 03:30 PM IST",
    "bse_nse_vol": "80.07 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 30, 2026",
    "traded_date_str": "2026 06 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sms-pharma-517655-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "SMS Pharmaceuticals Ltd Surges 10.53% to Day's High of Rs 423.4 — Outperforms Sector by 10.34 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-hits-intraday-high-with-1053-surge-on-30-june-2026-4079029",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_priceRelatedfactors_4079029.png",
        "date": "2026-06-30 13:16:24",
        "description": "The Sensex slipped 0.07% while SMS Pharmaceuticals Ltd surged 10.53% on 30 Jun 2026, marking a remarkable 10.34-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers. The stock's intraday high of Rs 423.4 was accompanied by elevated volatility, underscoring a strong, stock-specific rally in an otherwise subdued market environment."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Elevated Price Risk Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-elevated-price-risk-amid-strong-returns-4077672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_valuationdot_4077672.png",
        "date": "2026-06-30 08:00:40",
        "description": "SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating as of late May 2026. Despite this, the small-cap pharmaceutical company continues to deliver robust returns, outperforming the Sensex significantly over multiple time horizons. This article analyses the recent valuation changes, compares SMS Pharma’s metrics with its peers, and assesses the implications for investors."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4076983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_mojoScore_4076983.png",
        "date": "2026-06-29 10:10:05",
        "description": "SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Premium",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-premium-4069472",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_valuationdot_4069472.png",
        "date": "2026-06-24 08:00:28",
        "description": "SMS Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns well above the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid evolving market conditions."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4061131",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_mojoScore_4061131.png",
        "date": "2026-06-18 10:10:04",
        "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 18 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Risk Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-valuation-shifts-signal-heightened-price-risk-amid-strong-returns-4045705",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_valuationdot_4045705.png",
        "date": "2026-06-11 08:00:33",
        "description": "SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns that have significantly outpaced the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics, compares them with peer averages, and assesses the implications for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4037585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_mojoScore_4037585.png",
        "date": "2026-06-07 10:10:20",
        "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sms-pharmaceuticals-ltd-is-rated-sell-4037669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SMSPharmaceutic_mojoScore_4037669.png",
        "date": "2026-06-06 10:10:19",
        "description": "SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "SMS Pharmaceuticals Ltd Falls 3.02%: Quality and Valuation Concerns Weigh on Stock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sms-pharmaceuticals-ltd-falls-302-quality-and-valuation-concerns-weigh-on-stock-4023468",
        "imagepath": "",
        "date": "2026-05-30 17:06:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Sharp 10.54% intraday price drop to Rs.381.20 amid mixed technical signals</p>\n                    <p><strong>25 May:</strong> Valuation grade shifts from very expensive to expensive</p>\n                    <p><strong>26 May:</strong> Quality grade downgraded from Hold to Sell; stock closes at Rs.370.25 (-2.87%)</p>\n                    <p><strong>26 May:</strong> MarketsMOJO downgrades SMS Pharmaceuticals Ltd to Sell rating</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.381.20</div></div>\n                    <div class=\"stat-item\"><div ..."
      }
    ],
    "total": 773,
    "sid": "517655",
    "stock_news_url": "https://www.marketsmojo.com/news/sms-pharmaceuticals-517655"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Jun-2026",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015.",
      "datetime": "05-Jun-2026",
      "details": "Please find the annexure",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "30-May-2026",
      "details": "Transcripts of the Conference call held on 27th May 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "SMS Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 17 Dec 15",
          "dt": "2015-12-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

SMS Pharmaceuticals Ltd Surges 10.53% to Day's High of Rs 423.4 — Outperforms Sector by 10.34 Percentage Points

2026-06-30 13:16:24

The Sensex slipped 0.07% while SMS Pharmaceuticals Ltd surged 10.53% on 30 Jun 2026, marking a remarkable 10.34-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers. The stock's intraday high of Rs 423.4 was accompanied by elevated volatility, underscoring a strong, stock-specific rally in an otherwise subdued market environment.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Signal Elevated Price Risk Amid Strong Returns

2026-06-30 08:00:40

SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating as of late May 2026. Despite this, the small-cap pharmaceutical company continues to deliver robust returns, outperforming the Sensex significantly over multiple time horizons. This article analyses the recent valuation changes, compares SMS Pharma’s metrics with its peers, and assesses the implications for investors.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-06-29 10:10:05

SMS Pharmaceuticals Ltd is rated Sell by MarketsMOJO. This rating was last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Premium

2026-06-24 08:00:28

SMS Pharmaceuticals Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns well above the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid evolving market conditions.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-06-18 10:10:04

SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 18 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Read full news article

SMS Pharmaceuticals Ltd Valuation Shifts Signal Heightened Price Risk Amid Strong Returns

2026-06-11 08:00:33

SMS Pharmaceuticals Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns that have significantly outpaced the Sensex over multiple time horizons. This article analyses the recent changes in key valuation metrics, compares them with peer averages, and assesses the implications for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-06-07 10:10:20

SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

SMS Pharmaceuticals Ltd is Rated Sell

2026-06-06 10:10:19

SMS Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.